Efficacy and Safety of Human Chorionic Gonadotropin Monotherapy for Men With Hypogonadal Symptoms and Normal Testosterone

Background Male hypogonadism has a prevalence of about 6% and is defined by two-morning testosterone levels below 300 ng/dl associated with symptoms. This definition presents a challenging problem for patients without other medical problems but with symptoms of low testosterone (T) who do not meet t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zucker, Isaac, Rainer, Quinn, Pai, Raghav K, Ramasamy, Ranjith, Masterson, Thomas A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246432/
https://www.ncbi.nlm.nih.gov/pubmed/35800844
http://dx.doi.org/10.7759/cureus.25543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246432/
https://www.ncbi.nlm.nih.gov/pubmed/35800844
http://dx.doi.org/10.7759/cureus.25543

Ejemplares similares